QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock
38.855 EUR
+0.1 (+0.26%)
QIA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 19 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA has a correct valuation and a medium growth rate. With these ratings, QIA could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
QIA had positive earnings in the past year.
In the past year QIA had a positive cash flow from operations.
QIA had positive earnings in each of the past 5 years.
Each year in the past 5 years QIA had a positive operating cash flow.
1.2 Ratios
The Return On Assets of QIA (6.19%) is better than 73.68% of its industry peers.
With a decent Return On Equity value of 11.11%, QIA is doing good in the industry, outperforming 73.68% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 7.44%, QIA is in line with its industry, outperforming 57.89% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QIA is below the industry average of 9.26%.
The last Return On Invested Capital (7.44%) for QIA is above the 3 year average (7.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROIC | 7.44% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
QIA has a better Profit Margin (19.58%) than 94.74% of its industry peers.
QIA's Profit Margin has declined in the last couple of years.
QIA has a Operating Margin of 27.02%. This is amongst the best in the industry. QIA outperforms 94.74% of its industry peers.
QIA's Operating Margin has improved in the last couple of years.
QIA has a Gross Margin of 64.10%. This is amongst the best in the industry. QIA outperforms 94.74% of its industry peers.
In the last couple of years the Gross Margin of QIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
Compared to 1 year ago, QIA has less shares outstanding
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
Compared to 1 year ago, QIA has an improved debt to assets ratio.
2.2 Solvency
QIA has an Altman-Z score of 3.50. This indicates that QIA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of QIA (3.50) is better than 63.16% of its industry peers.
QIA has a debt to FCF ratio of 4.50. This is a neutral value as QIA would need 4.50 years to pay back of all of its debts.
QIA has a Debt to FCF ratio of 4.50. This is in the better half of the industry: QIA outperforms 73.68% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that QIA is not too dependend on debt financing.
QIA has a better Debt to Equity ratio (0.45) than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Altman-Z | 3.5 |
ROIC/WACC0.91
WACC8.21%
2.3 Liquidity
QIA has a Current Ratio of 2.60. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.60, QIA belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a better Quick ratio (2.30) than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 8.18% over the past year.
QIA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.92% yearly.
Looking at the last year, QIA shows a small growth in Revenue. The Revenue has grown by 5.32% in the last year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)8.18%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
3.2 Future
Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.41% on average per year.
Based on estimates for the next years, QIA will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y7.77%
EPS Next 2Y7.68%
EPS Next 3Y8.33%
EPS Next 5Y9.41%
Revenue Next Year4.96%
Revenue Next 2Y5.54%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.24, which indicates a rather expensive current valuation of QIA.
QIA's Price/Earnings ratio is a bit cheaper when compared to the industry. QIA is cheaper than 73.68% of the companies in the same industry.
QIA is valuated rather cheaply when we compare the Price/Earnings ratio to 26.77, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 17.63, QIA is valued on the expensive side.
Based on the Price/Forward Earnings ratio, QIA is valued a bit cheaper than 68.42% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.35. QIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.24 | ||
| Fwd PE | 17.63 |
4.2 Price Multiples
QIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. QIA is cheaper than 68.42% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, QIA is valued a bit cheaper than the industry average as 73.68% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.96 | ||
| EV/EBITDA | 13.35 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.48
PEG (5Y)2.43
EPS Next 2Y7.68%
EPS Next 3Y8.33%
5. Dividend
5.1 Amount
With a yearly dividend of 0.55%, QIA is not a good candidate for dividend investing.
QIA's Dividend Yield is comparable with the industry average which is at 0.60.
With a Dividend Yield of 0.55, QIA pays less dividend than the S&P500 average, which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y7.68%
EPS Next 3Y8.33%
FRA:QIA (12/30/2025, 7:00:00 PM)
38.855
+0.1 (+0.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners84.59%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.43B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.55% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.31%
PT rev (3m)-0.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)-0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.24 | ||
| Fwd PE | 17.63 | ||
| P/S | 4.78 | ||
| P/FCF | 20.96 | ||
| P/OCF | 15.06 | ||
| P/B | 2.71 | ||
| P/tB | 12.42 | ||
| EV/EBITDA | 13.35 |
EPS(TTM)2.02
EY5.2%
EPS(NY)2.2
Fwd EY5.67%
FCF(TTM)1.85
FCFY4.77%
OCF(TTM)2.58
OCFY6.64%
SpS8.12
BVpS14.31
TBVpS3.13
PEG (NY)2.48
PEG (5Y)2.43
Graham Number25.51
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.19% | ||
| ROE | 11.11% | ||
| ROCE | 10.03% | ||
| ROIC | 7.44% | ||
| ROICexc | 10.67% | ||
| ROICexgc | 39.98% | ||
| OM | 27.02% | ||
| PM (TTM) | 19.58% | ||
| GM | 64.1% | ||
| FCFM | 22.82% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | 4.5 | ||
| Debt/EBITDA | 2.17 | ||
| Cap/Depr | 97.52% | ||
| Cap/Sales | 8.94% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 87.76% | ||
| Profit Quality | 116.56% | ||
| Current Ratio | 2.6 | ||
| Quick Ratio | 2.3 | ||
| Altman-Z | 3.5 |
F-Score8
WACC8.21%
ROIC/WACC0.91
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)8.18%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%4.04%
EPS Next Y7.77%
EPS Next 2Y7.68%
EPS Next 3Y8.33%
EPS Next 5Y9.41%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year4.96%
Revenue Next 2Y5.54%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.16%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%
QIAGEN N.V. / QIA.DE FAQ
What is the fundamental rating for QIA stock?
ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE.
What is the valuation status of QIAGEN N.V. (QIA.DE) stock?
ChartMill assigns a valuation rating of 4 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.
How profitable is QIAGEN N.V. (QIA.DE) stock?
QIAGEN N.V. (QIA.DE) has a profitability rating of 7 / 10.
What is the valuation of QIAGEN N.V. based on its PE and PB ratios?
The Price/Earnings (PE) ratio for QIAGEN N.V. (QIA.DE) is 19.24 and the Price/Book (PB) ratio is 2.71.
How financially healthy is QIAGEN N.V.?
The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.